BioMarin Pharmaceutical Inc. Stock Insider Trading
Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 17.253.
In total, the insiders bought 844 834 and sold 576 466 BMRN shares in the last 100 trades.
Date | Action | Amount | Person | Type |
May 23, 2023 | Buy | 4 190 | Slamon Dennis | Common Stock |
May 23, 2023 | Buy | 4 190 | Pyott David E I | Common Stock |
May 23, 2023 | Buy | 4 190 | Meier Richard A | Common Stock |
May 23, 2023 | Buy | 4 190 | Lawlis V Bryan | Common Stock |
May 23, 2023 | Buy | 4 190 | Hombach Robert J. | Common Stock |
May 23, 2023 | Buy | 4 190 | Ho Maykin | Common Stock |
May 23, 2023 | Buy | 4 190 | Heron Elaine J | Common Stock |
May 23, 2023 | Buy | 4 190 | Dere Willard H | Common Stock |
May 23, 2023 | Buy | 4 190 | Anderson Elizabeth M | Common Stock |
May 23, 2023 | Buy | 4 190 | Alles Mark J | Common Stock |
May 16, 2023 | Sell | 796 | Burkhart Erin | Common Stock |
Apr 28, 2023 | Buy | 317 | Davis George Eric | Common Stock |
May 16, 2023 | Sell | 210 | Davis George Eric | Common Stock |
May 12, 2023 | Buy | 8 500 | Meier Richard A | Common Stock |
May 12, 2023 | Sell | 6 137 | Meier Richard A | Common Stock |
May 12, 2023 | Sell | 8 500 | Meier Richard A | Stock Option (Right to Buy Common Stock) |
May 12, 2023 | Buy | 8 500 | Heron Elaine J | Common Stock |
May 12, 2023 | Sell | 6 137 | Heron Elaine J | Common Stock |
May 12, 2023 | Sell | 8 500 | Heron Elaine J | Stock Option (Right to Buy Common Stock) |
May 12, 2023 | Buy | 39 130 | Bienaime Jean Jacques | Common Stock |
May 12, 2023 | Buy | 7 370 | Bienaime Jean Jacques | Common Stock |
May 12, 2023 | Sell | 6 337 | Bienaime Jean Jacques | Common Stock |
May 12, 2023 | Sell | 33 644 | Bienaime Jean Jacques | Common Stock |
May 12, 2023 | Sell | 7 370 | Bienaime Jean Jacques | Stock Option (Right to Buy Common Stock) |
May 11, 2023 | Buy | 30 000 | Bienaime Jean Jacques | Common Stock |
May 11, 2023 | Sell | 24 439 | Bienaime Jean Jacques | Common Stock |
May 11, 2023 | Sell | 5 561 | Bienaime Jean Jacques | Common Stock |
May 11, 2023 | Sell | 30 000 | Bienaime Jean Jacques | Stock Option (Right to Buy Common Stock) |
Apr 28, 2023 | Buy | 317 | Bienaime Jean Jacques | Common Stock |
May 10, 2023 | Buy | 30 000 | Bienaime Jean Jacques | Common Stock |
May 09, 2023 | Sell | 13 626 | Bienaime Jean Jacques | Common Stock |
May 09, 2023 | Sell | 14 964 | Bienaime Jean Jacques | Common Stock |
May 09, 2023 | Sell | 1 410 | Bienaime Jean Jacques | Common Stock |
May 10, 2023 | Sell | 21 453 | Bienaime Jean Jacques | Common Stock |
May 10, 2023 | Sell | 8 547 | Bienaime Jean Jacques | Common Stock |
May 09, 2023 | Sell | 30 000 | Bienaime Jean Jacques | Stock Option (Right to Buy Common Stock) |
May 09, 2023 | Sell | 30 000 | Bienaime Jean Jacques | Stock Option (Right to Buy Common Stock) |
Apr 28, 2023 | Buy | 239 | Guyer Charles Greg | Common Stock |
May 04, 2023 | Sell | 4 302 | Guyer Charles Greg | Common Stock |
Apr 10, 2023 | Buy | 10 000 | Bienaime Jean Jacques | Common Stock |
Apr 10, 2023 | Sell | 10 000 | Bienaime Jean Jacques | Common Stock |
Apr 10, 2023 | Sell | 10 000 | Bienaime Jean Jacques | Stock Option (Right to Buy Common Stock) |
Apr 06, 2023 | Buy | 10 000 | Bienaime Jean Jacques | Common Stock |
Apr 06, 2023 | Sell | 10 000 | Bienaime Jean Jacques | Common Stock |
Apr 06, 2023 | Sell | 10 000 | Bienaime Jean Jacques | Stock Option (Right to Buy Common Stock) |
Apr 03, 2023 | Buy | 8 500 | Lawlis V Bryan | Common Stock |
Apr 03, 2023 | Sell | 8 500 | Lawlis V Bryan | Common Stock |
Apr 03, 2023 | Sell | 8 500 | Lawlis V Bryan | Stock Option (Right to Buy Common Stock) |
Mar 15, 2023 | Buy | 8 900 | Guyer Charles Greg | Common Stock |
Mar 15, 2023 | Sell | 1 856 | Guyer Charles Greg | Common Stock |
Mar 15, 2023 | Buy | 20 320 | Guyer Charles Greg | Stock Option (Right to buy Common Stock) |
Mar 15, 2023 | Buy | 9 630 | Mueller Brian | Common Stock |
Mar 15, 2023 | Sell | 2 708 | Mueller Brian | Common Stock |
Mar 16, 2023 | Sell | 3 973 | Mueller Brian | Common Stock |
Mar 15, 2023 | Buy | 21 970 | Mueller Brian | Stock Option (Right to buy Common Stock) |
Mar 15, 2023 | Buy | 16 840 | Fuchs Henry J | Common Stock |
Mar 15, 2023 | Sell | 4 799 | Fuchs Henry J | Common Stock |
Mar 16, 2023 | Sell | 36 000 | Fuchs Henry J | Common Stock |
Mar 15, 2023 | Buy | 38 450 | Fuchs Henry J | Stock Option (Right to buy Common Stock) |
Mar 15, 2023 | Buy | 8 900 | Davis George Eric | Common Stock |
Mar 15, 2023 | Sell | 3 025 | Davis George Eric | Common Stock |
Mar 16, 2023 | Sell | 19 957 | Davis George Eric | Common Stock |
Mar 15, 2023 | Buy | 20 320 | Davis George Eric | Stock Option (Right to buy Common Stock) |
Mar 15, 2023 | Buy | 3 760 | Burkhart Erin | Common Stock |
Mar 15, 2023 | Buy | 5 720 | Burkhart Erin | Stock Option (Right to buy Common Stock) |
Mar 15, 2023 | Buy | 36 100 | Bienaime Jean Jacques | Common Stock |
Mar 15, 2023 | Sell | 9 437 | Bienaime Jean Jacques | Common Stock |
Mar 16, 2023 | Sell | 88 623 | Bienaime Jean Jacques | Common Stock |
Mar 15, 2023 | Buy | 49 430 | Bienaime Jean Jacques | Stock Option (Right to buy Common Stock) |
Mar 15, 2023 | Buy | 10 110 | Ajer Jeffrey Robert | Common Stock |
Mar 15, 2023 | Sell | 3 971 | Ajer Jeffrey Robert | Common Stock |
Mar 16, 2023 | Sell | 20 510 | Ajer Jeffrey Robert | Common Stock |
Mar 15, 2023 | Buy | 23 070 | Ajer Jeffrey Robert | Stock Option (Right to buy Common Stock) |
Mar 10, 2023 | Buy | 15 000 | Bienaime Jean Jacques | Common Stock |
Mar 10, 2023 | Sell | 15 000 | Bienaime Jean Jacques | Common Stock |
Mar 13, 2023 | Buy | 8 000 | Bienaime Jean Jacques | Common Stock |
Mar 13, 2023 | Sell | 8 000 | Bienaime Jean Jacques | Common Stock |
Mar 10, 2023 | Sell | 15 000 | Bienaime Jean Jacques | Stock Option (Right to buy Common Stock) |
Mar 13, 2023 | Sell | 8 000 | Bienaime Jean Jacques | Stock Option (Right to buy Common Stock) |
Feb 28, 2023 | Buy | 12 660 | Mueller Brian | Common Stock |
Feb 28, 2023 | Buy | 10 980 | Mueller Brian | Common Stock |
Feb 28, 2023 | Buy | 1 250 | Mueller Brian | Common Stock |
Feb 28, 2023 | Buy | 20 200 | Davis George Eric | Common Stock |
Feb 28, 2023 | Buy | 10 100 | Davis George Eric | Common Stock |
Feb 28, 2023 | Buy | 7 424 | Davis George Eric | Common Stock |
Feb 28, 2023 | Buy | 20 760 | Ajer Jeffrey Robert | Common Stock |
Feb 28, 2023 | Buy | 10 380 | Ajer Jeffrey Robert | Common Stock |
Feb 28, 2023 | Buy | 7 629 | Ajer Jeffrey Robert | Common Stock |
Feb 28, 2023 | Buy | 36 440 | Fuchs Henry J | Common Stock |
Feb 28, 2023 | Buy | 18 220 | Fuchs Henry J | Common Stock |
Feb 28, 2023 | Buy | 13 392 | Fuchs Henry J | Common Stock |
Feb 28, 2023 | Buy | 89 700 | Bienaime Jean Jacques | Common Stock |
Feb 28, 2023 | Buy | 44 860 | Bienaime Jean Jacques | Common Stock |
Feb 28, 2023 | Buy | 32 972 | Bienaime Jean Jacques | Common Stock |
Feb 24, 2023 | Buy | 1 474 | Davis George Eric | Common Stock |
Feb 24, 2023 | Sell | 1 474 | Davis George Eric | Stock Option (Right to buy Common Stock) |
Feb 07, 2023 | Sell | 200 | Bienaime Jean Jacques | Common Stock |
Feb 07, 2023 | Buy | 100 | Bienaime Jean Jacques | Common Stock |
Feb 10, 2023 | Buy | 15 000 | Bienaime Jean Jacques | Common Stock |
Feb 10, 2023 | Sell | 15 000 | Bienaime Jean Jacques | Common Stock |
About BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.